Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease
- 24 January 2023
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 101 (3) , 511-519
Abstract
Background: Patients with chronic kidney disease (CKD) are at higher risk of ischemic and bleeding events after percutaneous coronary intervention (PCI). Complex PCI (CPCI) is associated with higher rates of ischemic complications. Whether CPCI confers an additive risk of adverse events in CKD patients is unclear.Methods: Patients who underwent PCI at a single tertiary‐care‐center between 2012 and 2019 were stratified by CKD status and CPCI. The primary outcome was major adverse cardiac events (MACE), a composite of all‐cause death, myocardial infarction (MI), and target‐vessel revascularization (TVR) at 1‐year follow‐up. Secondary outcomes included the individual components of the primary outcome and major bleeding.Results: Out of 15,071 patients, 4537 (30.1%) had CKD and 10,534 (69.9%) had no CKD. Patients undergoing CPCI were 1151 (25.4%) and 2983 (28.3%) in the two cohorts, respectively. At one year, CPCI compared with no CPCI was associated with higher risk of MACE in both CKD (Adj. HR 1.72, 95% confidence interval [CI] 1.45−2.06, p < 0.001) and no‐CKD patients (Adj. hazard ratios [HR] 2.19, 95% CI 1.91−2.51, p < 0.001; p of interaction 0.057), determined by an excess of death, MI and TVR in CKD patients and of TVR and MI only in no‐CKD. CPCI was related with a consistent increase of major bleeding in the CKD (Adj. HR 1.49, 95% CI 1.18−1.87, p < 0.001) and no‐CKD group (Adj. HR 1.23, 95% CI 0.98−1.54, p = 0.071, p of interaction 0.206).Conclusion: At 1‐year follow‐up, CPCI was associated with higher risk of MACE and major bleeding irrespective of concomitant CKD. CPCI predicted mortality in CKD patients only.Keywords
This publication has 39 references indexed in Scilit:
- Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice GuidelineAnnals of Internal Medicine, 2013
- Value of Age, Creatinine, and Ejection Fraction (ACEF Score) in Assessing Risk in Patients Undergoing Percutaneous Coronary Interventions in the ‘All-Comers' LEADERS TrialCirculation: Cardiovascular Interventions, 2011
- Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: Results from SYNERGYInternational Journal of Cardiology, 2010
- Stenting of complex lesions: an overviewNature Reviews Cardiology, 2010
- Contemporary Mortality Risk Prediction for Percutaneous Coronary InterventionJACC, 2010
- Influence of Renal Function on the Effects of Early Revascularization in Non-ST-Elevation Myocardial InfarctionCirculation, 2009
- In-Hospital and 1-Year Outcomes Among Percutaneous Coronary Intervention Patients With Chronic Kidney Disease in the Era of Drug-Eluting StentsJACC: Cardiovascular Interventions, 2009
- Chronic Kidney DiseaseCirculation, 2007
- Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general populationEuropean Heart Journal, 2006
- THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Clinical Epidemiology of Cardiovascular Disease in Chronic Kidney Disease Prior to DialysisSeminars in Dialysis, 2003